It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2020.
2020 | New Delhi, Delhi, India | ActiveLyfeed Pharmaceuticals Private Limited, a active private limited company, was established on 13 January 2020 in New Delhi, Delhi, India. Engaging in human health activities within the trade sector, it holds CIN: U85100DL2020PTC360186. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Snigdha Rani Bhuyan (Director), Narayan Chandra Rout (Director). Past directors included Satyajit Rout, Narayan Chandra Rout. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No 153,Right Portion First Floor Village,Mangolpur Kalan,Rohini, New Delhi, Delhi, 110085.
U85100DL2020PTC360186
360186
13 January 2020
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Lyfeed Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Snigdha Rani Bhuyan | Director | 13 Jan 2020 | Current |
| Narayan Chandra Rout | Director | 27 Dec 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Dec 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lyfeed Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.08% increase. The company also saw a substantial fall in profitability, with a 35.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 181.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Lyfeed Pharmaceuticals had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Lyfeed Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lyfeed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lyfeed Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Lyfeed Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Lyfeed Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Narayan Chandra Rout was appointed as a Director was appointed as a Director on 27 Dec 2021 & has been associated with this company since 3 years 11 months . was recorded as a recent event.
The activity Snigdha Rani Bhuyan was appointed as a Director was appointed as a Director on 13 Jan 2020 & has been associated with this company since 5 years 11 months . was completed.
The activity Lyfeed Pharmaceuticals Private Limited was registered on 13 Jan 2020 with Roc Delhi & aged 5 years 11 months as per MCA records. was completed.
The CIN of Lyfeed Pharmaceuticals Private Limited is U85100DL2020PTC360186.
Lyfeed Pharmaceuticals Private Limited is headquartered at H.No 153,Right Portion First Floor Village,Mangolpur Kalan,Rohini, New Delhi, Delhi, 110085.
Lyfeed Pharmaceuticals Private Limited was incorporated on 13 January 2020.
The current directors of Lyfeed Pharmaceuticals Private Limited are
The primary industry of Lyfeed Pharmaceuticals Private Limited is Trade.
Lyfeed Pharmaceuticals Private Limited is unlisted.
The authorized capital of Lyfeed Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX